Insider · CIK 0001205903

RASTETTER WILLIAM H

Reports to the SEC for 8 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001205903

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-16	IAMIambic Therapeutics, Inc.C Conversion	Director, Chairperson of the Board	CConversion	+193K sh	—	—	192,579
2026-10-16	IAMIambic Therapeutics, Inc.C Conversion	Director, Chairperson of the Board	CConversion	+8,341 sh	—	—	200,920
2026-10-16	IAMIambic Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	Director, Chairperson of the Board	CConversion	−76.8K sh	—	—	0
2026-10-16	IAMIambic Therapeutics, Inc. · Series B-2 Convertible Preferred StockC Conversion	Director, Chairperson of the Board	CConversion	−64K sh	—	—	0
2026-10-16	IAMIambic Therapeutics, Inc. · Series B-3 Convertible Preferred StockC Conversion	Director, Chairperson of the Board	CConversion	−36.8K sh	—	—	0
2026-10-16	IAMIambic Therapeutics, Inc. · Series B-4 Convertible Preferred StockC Conversion	Director, Chairperson of the Board	CConversion	−15K sh	—	—	0
2026-10-16	IAMIambic Therapeutics, Inc. · Convertible Promissory NotesC Conversion	Director, Chairperson of the Board	CConversion	−8,341 sh	—	—	0
2026-10-14	IAMIambic Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairperson of the Board	AAward	+40.6K sh	—	—	40,600
2026-06-30	DAREDare Bioscience, Inc.A Award	Director	AAward	+38.9K sh	—	—	39,721
2026-06-12	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+87.9K sh	—	—	87,900
2026-06-11	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2026-05-27	NBIXNEUROCRINE BIOSCIENCES INC · Restriced Stock UnitA Award	Director	AAward	+2,567 sh	—	—	2,567
2026-05-21	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+3,318 sh	—	—	43,678
2026-05-21	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,318 sh	—	—	0
2026-05-05	FATEFATE THERAPEUTICS INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$1.69	+$42.3K	36,331
2026-05-05	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	—	—	0
2025-11-05	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+18K sh	$47.89	+$862K	58,360
2025-11-05	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director	SSale	−18K sh	$151.82	−$2.73M	40,360
2025-11-05	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2025-07-09	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,500 sh	—	—	4,500
2025-06-25	Regulus Therapeutics Inc.U Disposition from Tender	Director	UDisposition from Tender	−44.3K sh	—	—	57,292
2025-06-25	Regulus Therapeutics Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−57.3K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−4,650 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−2,325 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−60K sh	—	—	0
2025-05-29	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2025-05-22	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+2,869 sh	—	—	40,360
2025-05-22	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,869 sh	—	—	0
2025-05-21	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director	AAward	+3,318 sh	—	—	3,318
2025-05-05	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$42.76	+$1.28M	67,491
2025-05-05	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director	SSale	−30K sh	$110.20	−$3.31M	37,491
2025-05-05	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2025-04-30	Regulus Therapeutics Inc.A Award	Director	AAward	+62.5K sh	—	—	101,556
2024-08-15	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director	SSale	−14.3K sh	$146.69	−$2.09M	37,491
2024-06-07	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-06-05	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-05-22	NBIXNEUROCRINE BIOSCIENCES INC · Restricted Stock UnitA Award	Director	AAward	+2,869 sh	—	—	2,869
2024-05-20	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2024-05-16	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-01-02	NBIXNEUROCRINE BIOSCIENCES INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$12.98	+$260K	62,785
2024-01-02	NBIXNEUROCRINE BIOSCIENCES INCS Sale	Director	SSale	−11K sh	$131.47	−$1.45M	51,741
2024-01-02	NBIXNEUROCRINE BIOSCIENCES INC · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	$12.98	−$260K	0
2023-08-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-06-21	DAREDare Bioscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-06-13	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Oct 194
RASTETTER WILLIAM H0001205903-26-000013
SEC(opens sec.gov)
Oct 164
RASTETTER WILLIAM H0001205903-26-000011
SEC(opens sec.gov)
Jul 24
RASTETTER WILLIAM H0001401914-26-000034
SEC(opens sec.gov)
Jun 154
RASTETTER WILLIAM H0001193125-26-271072
SEC(opens sec.gov)
Jun 114
RASTETTER WILLIAM H0001205903-26-000005
SEC(opens sec.gov)
May 294
RASTETTER WILLIAM H0001205903-26-000004
SEC(opens sec.gov)
May 214
RASTETTER WILLIAM H0001205903-26-000002
SEC(opens sec.gov)
May 64
RASTETTER WILLIAM H0001193125-26-208891
SEC(opens sec.gov)
Nov 64
RASTETTER WILLIAM H0001205903-25-000005
SEC(opens sec.gov)
Jul 104
RASTETTER WILLIAM H0001401914-25-000040
SEC(opens sec.gov)

Companies

Address

C/O IAMBIC THERAPEUTICS, INC. 5627 OBERLIN DRIVE, SUITE 120

SAN DIEGO, CA, 92121